T. Yoshioka

Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia.

W. Zeng, T. Yoshioka, M. Yasukawa, 1997, Blood.

Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation

Y. Maeda, K. Matsuoka, T. Yoshioka, 2022, Frontiers in Immunology.

Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study

H. Ueda, T. Yoshioka, T. Moriyama, 2020, International Journal of Clinical Oncology.

Angioimmunoblastic T-cell Lymphoma Presenting as a Methotrexate-associated Lymphoproliferative Disorder with Extreme Peripheral Blood Plasmacytosis

T. Yoshino, Y. Maeda, T. Yoshioka, 2022, Internal medicine.

Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group

Y. Maeda, Hideaki Fujiwara, K. Matsuoka, 2022, International Journal of Hematology.

PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.

J. Ritz, M. Tanimoto, P. Armand, 2017, Blood.

Comprehensive Analyses of Early Lymphocyte Reconstitution after Haploidentical HSCT with Posttransplant Cyclophosphamide: Coordinated Treg-Dominant T-Cell Reconstitution and Stem Cell-Derived Mature B-Cell with Broad BCR-Repertoir Diversity

M. Tanimoto, R. Suzuki, Y. Maeda, 2016 .

Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels.

Y. Maeda, E. Kondo, K. Matsuoka, 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

PD-1 modulates regulatory T cell homeostasis during low-dose IL-2 therapy

J. Ritz, M. Tanimoto, P. Armand, 2017 .

High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura

H. Iwasaki, A. Yokoyama, H. Nagai, 2020, International Journal of Hematology.